EDITAS MEDICINE, INC. Increase (Decrease) in Other Noncurrent Assets
EDITAS MEDICINE, INC. (EDIT) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- EDITAS MEDICINE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$14.00K.
- EDITAS MEDICINE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$1.00K.
- EDITAS MEDICINE, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$1.04M.
- EDITAS MEDICINE, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$3.37M, a 200.93% decline from fiscal 2023.
- EDITAS MEDICINE, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $3.33M.
- EDITAS MEDICINE, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was -$1.56M, a 173.91% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | -$14.00K derived: sum of 3 quarters · filed 2026-08-05 | -$15.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | -$14.00K derived: sum of 2 quarters · filed 2026-05-05 | -$15.00K derived: sum of 3 quarters · filed 2026-05-05 | -$15.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$15.00K derived: sum of 2 quarters · filed 2026-03-09 | -$15.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.04M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.00K derived: sum of 2 quarters · filed 2026-08-05 | -$1.03M 10-Q · filed 2025-11-10 | -$1.09M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.02M 10-Q · filed 2026-08-05 | -$1.08M derived: sum of 3 quarters · filed 2026-08-05 | -$3.95M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$1.02M 10-Q · filed 2026-05-05 | -$1.08M derived: sum of 2 quarters · filed 2026-05-05 | -$3.95M derived: sum of 3 quarters · filed 2026-05-05 | -$5.29M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$2.92M derived: sum of 2 quarters · filed 2026-03-09 | -$4.26M derived: sum of 3 quarters · filed 2026-03-09 | -$3.37M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | -$2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$4.21M derived: sum of 2 quarters · filed 2025-11-10 | -$3.31M 10-Q · filed 2025-11-10 | -$473.00K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$443.00K 10-Q · filed 2025-08-12 | $2.39M derived: sum of 3 quarters · filed 2025-08-12 | $2.89M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $899.00K 10-Q · filed 2025-05-12 | $3.73M derived: sum of 2 quarters · filed 2025-05-12 | $4.23M derived: sum of 3 quarters · filed 2025-05-12 | $2.73M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $3.33M derived: sum of 2 quarters · filed 2025-03-05 | $1.83M derived: sum of 3 quarters · filed 2025-03-05 | $3.33M 10-K · filed 2025-03-05 | |||
| 2023-09-30 | $502.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$998.00K derived: sum of 2 quarters · filed 2024-11-04 | $502.00K 10-Q · filed 2024-11-04 | -$1.77M derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2023-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | -$2.28M derived: sum of 3 quarters · filed 2025-03-05 | -$2.28M derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-08 | -$777.00K derived: sum of 2 quarters · filed 2025-03-05 | -$777.00K derived: sum of 3 quarters · filed 2025-03-05 | -$563.00K derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2022-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$2.28M derived: sum of 2 quarters · filed 2025-03-05 | -$2.06M derived: sum of 3 quarters · filed 2025-03-05 | -$1.56M 10-K · filed 2025-03-05 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $214.00K derived: sum of 2 quarters · filed 2023-11-03 | $719.00K 10-Q · filed 2023-11-03 | $750.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $719.00K 10-Q · filed 2023-08-02 | $750.00K derived: sum of 3 quarters · filed 2024-02-28 | $750.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | $505.00K 10-Q · filed 2023-05-05 | $536.00K derived: sum of 2 quarters · filed 2024-02-28 | $536.00K derived: sum of 3 quarters · filed 2024-02-28 | $628.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $31.00K derived: sum of 2 quarters · filed 2024-02-28 | $123.00K derived: sum of 3 quarters · filed 2024-02-28 | $2.11M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $92.00K derived: sum of 2 quarters · filed 2022-11-02 | $2.08M 10-Q · filed 2022-11-02 | $2.90M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.08M 10-Q · filed 2022-08-03 | $2.90M derived: sum of 3 quarters · filed 2023-02-22 | $2.89M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $1.99M 10-Q · filed 2022-05-04 | $2.81M derived: sum of 2 quarters · filed 2023-02-22 | $2.80M derived: sum of 3 quarters · filed 2023-02-22 | $2.80M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $825.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $812.00K derived: sum of 2 quarters · filed 2023-02-22 | $812.00K derived: sum of 3 quarters · filed 2023-02-22 | $719.00K 10-K · filed 2023-02-22 | |||
| 2020-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$13.00K derived: sum of 2 quarters · filed 2021-11-09 | -$106.00K 10-Q · filed 2021-11-09 | -$105.00K derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$93.00K 10-Q · filed 2021-08-05 | -$92.00K derived: sum of 3 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$93.00K 10-Q · filed 2021-05-06 | -$92.00K derived: sum of 2 quarters · filed 2022-02-24 | |||||
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $15.00K 10-K · filed 2022-02-24 | |||||
| 2019-09-30 | $14.00K 10-Q · filed 2020-11-06 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $92.00K 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $92.00K 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $92.00K 10-Q · filed 2019-08-07 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $0.00 derived: sum of 2 quarters · filed 2020-02-26 | $0.00 derived: sum of 3 quarters · filed 2020-02-26 | -$2.00K 10-K · filed 2020-02-26 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | -$2.00K 10-Q · filed 2018-11-08 | -$13.00K derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$2.00K 10-Q · filed 2018-08-07 | -$13.00K derived: sum of 3 quarters · filed 2019-03-01 | -$24.00K derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | -$2.00K 10-Q · filed 2018-05-04 | -$13.00K derived: sum of 2 quarters · filed 2019-03-01 | -$24.00K derived: sum of 3 quarters · filed 2019-03-01 | $0.00 derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$22.00K derived: sum of 2 quarters · filed 2019-03-01 | $2.00K derived: sum of 3 quarters · filed 2019-03-01 | -$2.25M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $13.00K derived: sum of 2 quarters · filed 2017-11-08 | -$2.23M 10-Q · filed 2017-11-08 | $2.23M 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$2.22M 10-Q · filed 2017-08-09 | $2.22M 10-Q · filed 2016-08-10 | ||||
| 2016-03-31 | -$2.25M 10-Q · filed 2017-05-15 | $2.25M 10-Q · filed 2016-05-13 | |||||
| 2015-12-31 | -$40.00K 10-K · filed 2017-03-03 | ||||||
| 2015-06-30 | $20.00K 10-Q · filed 2016-08-10 | ||||||
| 2014-12-31 | $20.00K 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |